These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 9162298)

  • 1. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
    Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition.
    Reszka E; Wasowicz W; Rydzynski K; Szeszenia-Dabrowska N; Szymczak W
    Neoplasma; 2003; 50(5):357-62. PubMed ID: 14628089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
    Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
    Habalová V; Salagovic J; Kalina I; Stubna J
    Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
    Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
    Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
    Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
    Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M; Tagawa M; Kimura H; Kakisawa K; Shirasawa H; Fujisawa T
    Int J Oncol; 1998 Mar; 12(3):577-81. PubMed ID: 9472095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.